Optometry Education and CME

Select a Specialty

J194
CME

Neovascular Retinal Disease: Examining Emerging Trends in Treatment

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 9/11/2020
Credit Type(s): CME | Credit: 0.75

The integration of intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy into management protocols for the treatment of neovascular retinal disease…

go to activity»
Looking to the Horizon: Earlier Diagnosis and Advances in Treating Neovascular Age-Related Macular Degeneration

nAMD is an incurable disease and can lead to permanent vision loss. nAMD imposes a high burden on patients and eye care providers alike, as optimal visual outcomes have…

go to activity»
Looking to the Horizon: Earlier Diagnosis and Advances in Treating Neovascular Age-Related Macular Degeneration

nAMD is an incurable disease and can lead to permanent vision loss. nAMD imposes a high burden on patients and eye care providers alike, as optimal visual outcomes have…

go to activity»
Ocular Surface Diseases, Disorders, and Dysfunctions®: Volume 5, Number 1
CMECOPE

Ocular Surface Diseases, Disorders, and Dysfunctions®: Volume 5, Number 1

This activity is supported by an educational grant from Shire.

Expiration Date: 7/1/2020
Credit Type(s): CME / COPE | Credit: 1.25

Early identification and prompt management of patients with ocular surface disease (OSD) can lessen disease severity and achieve earlier resolution. However, OSD…

go to activity»
A Clear Choice for Patients and Practices is CLEAR CARE® PLUS

A Clear Choice for Patients and Practices is CLEAR CARE® PLUS

This activity is sponsored by Alcon.

June 14, 2019

Learn about a lens care solution that can make a difference for your patients and your practice….

go to activity»
M439_HEA003
CME

When Anti-VEGF Agents Don’t Work: Using Intravitreal Steroids Alone or in Combination to Treat DME/DR—Vision Is More Than Just Best Corrected Visual Acuity in Diabetic Macular Edema

This activity is supported by an educational grant from Allergan, Inc.

Expiration Date: 4/30/2020
Credit Type(s): CME | Credit: 0.25

Explore the treatment options for a patient with diabetes and blurry vision presented by Dr Roger Goldberg with faculty discussion of treatment strategies and timing to…

go to activity»
Key Questions in nr-axSpA: Understanding, Recognizing, and Managing Patients With nr-axSpA

The term spondyloarthritis (SpA) encompasses a spectrum of related inflammatory conditions with a predominance of either axial or peripheral manifestations. The figure…

go to activity»
Looking to the Horizon: Earlier Diagnosis and Advances in Treating Neovascular Age-Related Macular Degeneration

nAMD is an incurable disease and can lead to permanent vision loss. nAMD imposes a high burden on patients and eye care providers alike, as optimal visual outcomes have…

go to activity»
Neovascular Age-related Macular Degeneration: Emerging Therapies with an EYE On Treatment Frequency
CME

Neovascular Age-related Macular Degeneration: Emerging Therapies With an EYE On Treatment Frequency

This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

Expiration Date: 8/27/2020
Credit Type(s): CME | Credit: 1.25

The treatment of neovascular age-related macular degeneration (nAMD) has been revolutionized through the introduction of intravitreal anti–vascular endothelial growth…

go to activity»
Visual Reality Diabetic Retinopathy
COPE

Visual Reality: Diabetic Retinopathy

This activity is supported by independent medical education grants from Optos North America and Regeneron Pharmaceuticals, Inc.

Expiration Date: 6/1/2020
Credit Type(s): COPE | Credit: 1

Diabetic retinopathy (DR) continues to be a leading cause of blindness. However, early diagnosis and prompt treatment with laser and/or intravitreal anti-vascular…

go to activity»
Advances in Cataract Surgical Techniques and Postoperative Care
CME

Advances in Cataract Surgical Techniques and Postoperative Care

This activity is supported by educational grants from Alcon Laboratories, Inc. and EyePoint Pharmaceuticals, Inc.

Expiration Date: 5/25/2020
Credit Type(s): CME | Credit: 1.25

New techniques for cataract surgery have emerged in rapid succession over the past few years. Some of these techniques have been demonstrated to provide clinically…

go to activity»
Diabetic Retinopathy: Assessing the Armamentarium for Improved Detection and Treatment
CME

Diabetic Retinopathy: Assessing the Armamentarium for Improved Detection and Treatment

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 4/11/2020
Credit Type(s): CME | Credit: 0.75

Anti-VEGF therapy is an important addition to the treatment options for diabetic retinopathy (DR) and is the only medical option that has been granted US Food and Drug…

go to activity»